Mechanical circulatory support in the form of ventricular assist devices (VADs) in children has undergone rapid growth in the last decade. With expansion of device options available for larger children and adolescents, the field of outpatient VAD support has flourished, with many programs unprepared for the clinical, programmatic, and administrative responsibilities. From preimplantation VAD evaluation and patient education to postimplant VAD management, the VAD program, staffed with an interdisciplinary team, is essential to providing safe, effective, and sustainable care for a new technology in an exceedingly complex patient population. Herein, this paper describes the Boston Children’s Hospital VAD experience over a decade and important lessons learned from developing a pediatric program focusing on a high-risk but low-volume population. We highlight the paramount role of the VAD coordinator, clinical infrastructure requirements, as well as innovation in care spanning inpatient and outpatient VAD supports at Boston Children’s Hospital.
Pediatric VAD Ventricular assist device VAD coordinator Outpatient VAD program Pediatric VAD program
This is a preview of subscription content, log in to check access.
This paper was supported in part by the Alexia Clinton Fund and the Cardiac Transplant Research and Education Fund.
Compliance with Ethical Standards
Conflict of interest
Dr Francis Fynn-Thompson acts as a proctor/consultant for HeartWare Inc. None of the other authors have any financial or otherwise conflicts of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
Blume ED, Rosenthal DN, Rossano JW et al (2016) Outcomes of children implanted with ventricular assist devices in the United States: first analysis of the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS). J Hear Lung Transplant. doi:10.1016/j.healun.2016.01.1227Google Scholar
Hollander SA, Hollander AJ, Rizzuto S et al (2014) An inpatient rehabilitation program utilizing standardized care pathways after paracorporeal ventricular assist device placement in children. J Hear Lung Transplant 33:587–592. doi:10.1016/j.healun.2013.12.009CrossRefGoogle Scholar
Rossano JW, Lorts A, VanderPluym CJ et al (2016) Outcomes of pediatric patients supported with continuous-flow ventricular assist devices: a report from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS). J Hear Lung Transplant. doi:10.1016/j.healun.2016.01.1228Google Scholar
Long JW, Kfoury AG, Slaughter MS et al (2005) Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail 11:133–138CrossRefPubMedGoogle Scholar
Rose EA, Moskowitz AJ, Packer M et al (1999) The REMATCH trial: rationale, design, and end points. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure. Ann Thorac Surg 67:723–730CrossRefPubMedGoogle Scholar